Top ▲


Target not currently curated in GtoImmuPdb

Target id: 1321

Nomenclature: CYP2A6

Family: CYP2 family

Annotation status:  image of a grey circle Awaiting annotation/under development. Please contact us if you can help with annotation.  » Email us

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - - CYP2A6 cytochrome P450 family 2 subfamily A member 6
Previous and Unofficial Names
Coumarin 7-hydroxylase | cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 6 | 1,4-cineole 2-exo-monooxygenase | CYP2A3 | Cytochrome P450 IIA3 | cytochrome P450, family 2, subfamily A, polypeptide 6
Database Links
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Enzyme
Enzyme Reaction
EC Number:
Substrates and Reaction Kinetics
Substrate Sp. Property Value Units Standard property Standard value Assay description Assay conditions Comments Reference
nicotine N/A - -

Download all structure-activity data for this target as a CSV file

Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
compound 38a [PMID: 15634016] Hs Inhibition 7.7 pKi 2
pKi 7.7 (Ki 2x10-8 M) [2]
compound 39a [PMID: 15634016] Hs Inhibition 7.4 pKi 2
pKi 7.4 (Ki 4x10-8 M) [2]
compound 23 [PMID: 17125252] Hs Inhibition 6.2 pKi 6
pKi 6.2 (Ki 6x10-7 M) [6]
Inhibitor Comments
Additional CYP2A6 inhibitors are reported in [5].
General Comments
CYP2A6 is the major nicotine metabolising enzyme and is believed to be involved in the generation of mutagenic tobacco-related nitrosamines [1,3-4]. CYP2A6 inhibiting compounds are of interest to the pharmaceutical industry as these may be useful additional drugs for smoking cessation therapy [5].


Show »

1. Benowitz NL. (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N. Engl. J. Med., 319 (20): 1318-30. [PMID:3054551]

2. Denton TT, Zhang X, Cashman JR. (2005) 5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6. J. Med. Chem., 48 (1): 224-39. [PMID:15634016]

3. Hecht SS, Hoffmann D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9 (6): 875-84. [PMID:3286030]

4. Nakajima M, Kuroiwa Y, Yokoi T. (2002) Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6. Drug Metab. Rev., 34 (4): 865-77. [PMID:12487152]

5. Tani N, Juvonen RO, Raunio H, Fashe M, Leppänen J, Zhao B, Tyndale RF, Rahnasto-Rilla M. (2014) Rational design of novel CYP2A6 inhibitors. Bioorg. Med. Chem., 22 (23): 6655-64. [PMID:25458499]

6. Yano JK, Denton TT, Cerny MA, Zhang X, Johnson EF, Cashman JR. (2006) Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J. Med. Chem., 49 (24): 6987-7001. [PMID:17125252]

How to cite this page

Select citation format: